286 related articles for article (PubMed ID: 12455183)
1. Plasma homocysteine level and uveitis in Behçet's disease.
Okka M; Oztürk M; Kockar MC; Bavbek N; Rasier Y; Gunduz K
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):931-4. PubMed ID: 12455183
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine: an activity marker in Behçet's disease?
Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
[TBL] [Abstract][Full Text] [Related]
3. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.
Di Crecchio L; Parodi MB; Sanguinetti G; Iacono P; Ravalico G
Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372
[TBL] [Abstract][Full Text] [Related]
5. Role of hyperhomocystinemia in retinal vascular occlusive disease.
Sottilotta G; Oriana V; Latella C; Luise F; Piromalli A; Ramirez F; Mammi C; Occhiuto A; Lombardo VT
Clin Appl Thromb Hemost; 2007 Jan; 13(1):104-7. PubMed ID: 17164500
[TBL] [Abstract][Full Text] [Related]
6. Does lowering hyperhomocysteinemia by folic acid beneficial for oculo-Behcet's disease? A pilot study.
Houman MH; Naffati H; Khanfir M; Ghannouchi M; Ben Ghorbel I; Lamloum M; El Matri L; Hamzaoui K; Jeddi A; Miled M; Fki M
Tunis Med; 2007 Jun; 85(6):450-3. PubMed ID: 17644895
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine in vascular Behcet disease: a meta-analysis.
La Regina M; Orlandini F; Prisco D; Dentali F
Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2067-74. PubMed ID: 20634474
[TBL] [Abstract][Full Text] [Related]
8. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
9. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.
Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F
Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion.
Vine AK
Trans Am Ophthalmol Soc; 2000; 98():493-503. PubMed ID: 11190038
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia in central retinal vein occlusion in young adults.
Parodi MB; Di Crecchio L
Semin Ophthalmol; 2003 Sep; 18(3):154-9. PubMed ID: 15513477
[TBL] [Abstract][Full Text] [Related]
12. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
[TBL] [Abstract][Full Text] [Related]
13. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.
Ricart JM; Vayá A; Todolí J; Calvo J; Villa P; Estellés A; España F; Santaolaria M; Corella D; Aznar J
Thromb Haemost; 2006 Apr; 95(4):618-24. PubMed ID: 16601831
[TBL] [Abstract][Full Text] [Related]
14. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
[TBL] [Abstract][Full Text] [Related]
15. [Retinal vein occlusion and hyperhomocysteinemia].
Blondel J; Glacet-Bernard A; Bayani N; Blacher J; Lelong F; Nordmann JP; Coscas G; Soubrane G
J Fr Ophtalmol; 2003 Mar; 26(3):249-53. PubMed ID: 12746600
[TBL] [Abstract][Full Text] [Related]
16. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
17. Hyperhomocysteinaemia: risk of retinal vascular occlusion.
Yaghoubi GH; Madarshahian F; Mosavi M
East Mediterr Health J; 2004; 10(4-5):633-9. PubMed ID: 16335656
[TBL] [Abstract][Full Text] [Related]
18. Plasma homocysteine level in patients with Behcet's disease with or without thrombosis.
Shahram F; Faridar A; Hamedani MG; Nadji A; Naderi N; Mojarad Shafiee N; Rasker JJ; Davatchi F
Arch Iran Med; 2010 Nov; 13(6):476-81. PubMed ID: 21039001
[TBL] [Abstract][Full Text] [Related]
19. Anticardiolipin IgG antibody and homocysteine as possible risk factors for retinal vascular occlusive disease in thai patients.
Atchaneeyasakul LO; Trinavarat A; Bumrungsuk P; Wongsawad W
Jpn J Ophthalmol; 2005; 49(3):211-5. PubMed ID: 15944825
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinemia and low methionine stress are risk factors for central retinal venous occlusion in an Indian population.
Narayanasamy A; Subramaniam B; Karunakaran C; Ranganathan P; Sivaramakrishnan R; Sharma T; Badrinath VS; Roy J
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1441-6. PubMed ID: 17389469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
